Heejae Won

Dr. Heejae Won

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 April 2022 in Journal of Bone and Joint Surgery
Verified
Journal Article
Closed access
SBSeung-Hoon Baek
Seung-Hoon Baek
KKKwang-Hwan Kim
Kwang-Hwan Kim
WLWon Kee Lee
Won Kee Lee
WHWonki Hong
Wonki Hong
HWHeejae Won
Heejae Won
SKShin-Yoon Kim
Shin-Yoon Kim
Background: Abnormal lipid metabolism may play an important role in the development of nontraumatic osteonecrosis of the femoral head (ON). By comparing lipid biomarkers in patients with ON and osteoarthritis (OA) after propensity score matching, we sought to reveal (1) common lipid biomarkers that are abnormal in ON regardless of the etiology and (2) specific lipid biomarkers associated with ON according to the etiology. Methods: Among 2,268 patients who underwent primary THA, 1,021 patients were eligible for this study. According to the Association Research Circulation Osseous criteria, ON was classified as either idiopathic (n = 230), alcohol-associated (n = 293), or glucocorticoid-associated ON (n = 132). Most common cause of OA was hip dysplasia in 106 patients (47%). We investigated patient lipid profiles by assessing total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), triglycerides (TGs), apolipoprotein (Apo) A1 and B, lipoprotein (a) levels and ApoB/A1 ratio. Since age and body mass index affect the lipid profile, we performed propensity score matching to select 304 patients for final analysis and compared lipid profiles between the ON and OA groups. We also compared biomarkers between the ON subgroups and the OA group. Results: Overall, the ON group showed lower HDL-C (p < 0.001), higher TGs (p = 0.001) levels and higher ApoB/A1 ratio (p = 0.003). Idiopathic ON patients demonstrated lower HDL-C (p = 0.032), higher TGs (p = 0.016), ApoB (p = 0.024) levels and ApoB/A1 ratio (p = 0.008). The alcohol-associated ON subgroup showed lower HDL-C (p < 0.001), higher TGs (p = 0.010) levels and ApoB/A1 ratio (p = 0.030). Finally, the steroid-associated ON subgroup demonstrated lower HDL-C (p = 0.003), higher TGs (p = 0.039), lower TC (p = 0.022), LDL-C (p = 0.021), and ApoA1 (p = 0.004) levels. Conclusions: Higher TGs and lower HDL-C levels were associated with nontraumatic ON regardless of the etiology. Additionally, idiopathic ON was associated with higher ApoB levels and ApoB/A1 ratio. Alcohol-associated ON was related to higher ApoB/A1 ratio, and steroid-associated ON paired with decreased TC, LDL-C, and ApoA1 levels. Our findings may support future efforts for prevention and management of nontraumatic ON. Level of Evidence: Diagnostic Level III.

6 December 2020 in Orthopaedic Surgery
Verified
Journal Article
Open access
PDF file
HWHeejae Won
Heejae Won
SBSeung-Hoon Baek
Seung-Hoon Baek
CKCheol‐Hwan Kim
Cheol‐Hwan Kim
DKDong‐Hyeon Kim
Dong‐Hyeon Kim
JYJee‐Wook Yoon
Jee‐Wook Yoon
SKShin-Yoon Kim
Shin-Yoon Kim
Background Reconstruction intramedullary nail spanning the whole length of the femur has been the gold standard treatment for complete atypical diaphyseal fractures of the femur (ADF). However, in cases of incomplete ADF combined with severe bowing, this approach might have complications and lead to iatrogenic complete fracture. We report two cases of incomplete ADF with severe bowing using a precontoured plate (PCP) after rapid prototyping (RP) of the deformed femurs with three‐dimensional printing (3DP) technology. Case presentation Two patients presented with gradually worsening thigh pain, especially during walking. The patients had been using bisphosphonates for 4 and 10 years, respectively. Radiography showed an incomplete fracture in the lateral cortex of the right femur shaft. The lateral bowing angles measured in the affected femurs were 15° and 14°, and the anterior bowing angles were 20° and 16°, respectively. In bone scans, both patients showed hot uptake in the right mid‐shaft of the femur. Preoperatively, the affected femur of the patient was reconstructed by 3DP RP using CT, and the plate was bent to the shape of the bone model. The ADF was fixed with a PCP using the minimally invasive plate osteosynthesis technique. Both patients were encouraged to start full weight‐bearing and return to their preinjury activity level in daily life immediately after surgery. At 2 years postoperatively, radiography showed healing of the fracture site without recurrence of thigh pain and implant‐related problems. Conclusion Although intramedullary nailing is the standard surgical treatment for complete ADF, PCP using 3DP RP could be an effective treatment option for incomplete ADF with severely curved femur.

1 October 2020 in Injury
Verified
Journal Article
Closed access
HWHeejae Won
Heejae Won
SMSun-Young Moon
Sun-Young Moon
JPJae Hyun Park
Jae Hyun Park
JKJin-Kak Kim
Jin-Kak Kim
HKHong Seok Kim
Hong Seok Kim
KKKyung-Hoi Koo
Kyung-Hoi Koo

13 October 2024 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
SBSeung-Hoon Baek
Seung-Hoon Baek
BSBum Jin Shim
Bum Jin Shim
HWHeejae Won
Heejae Won
SLSunray Lee
Sunray Lee
YLYeon Kyung Lee
Yeon Kyung Lee
SKShin-Yoon Kim
Shin-Yoon Kim
Although mesenchymal stem cells (MSCs) insertion has gained recent attention as a joint-preserving procedure, no study has conducted direct intralesional implantation of human umbilical cord-derived MSCs (hUCMSCs) in patients with ONFH. This is a protocol for a phase 1 clinical trial designed to assess the safety and exploratory efficacy of human umbilical cord-derived osteoblasts (hUC-Os), osteogenic differentiation-induced cells from hUCMSCs, in patients with early-stage ONFH. Nine patients with Association Research Circulation Osseous (ARCO) stage 1 or 2 will be assigned to a low-dose (1 × 107 hUC-O cells, n = 3), medium-dose (2 × 107 cells, n = 3), and high-dose group (4 × 107 cells, n = 3) in the order of their arrival at the facility, and, depending on the occurrence of dose-limiting toxicity, up to 18 patients can be enrolled by applying the 3 + 3 escalation method. We will perform hUC-O (CF-M801) transplantation combined with core decompression and follow-up for 12 weeks according to the study protocol. Safety will be determined through adverse event assessment, laboratory tests including a panel reactive antibody test, vital sign assessment, physical examination, and electrocardiogram. Efficacy will be explored through the change in pain visual analog scale, Harris hip score, Western Ontario and McMaster Universities Osteoarthritis Index, ARCO stage, and also size and location of necrotic lesion according to Japanese Investigation Committee classification before and after the procedure. Joint preservation is important, particularly in younger, active patients with ONFH. Confirmation of the safety and efficacy of hUC-Os will lead to a further strategy to preserve joints for those suffering from ONFH and improve our current knowledge of cell therapy.

1 January 2018 in Journal of the Korean Fracture Society
Verified
Journal Article
Open access
PDF file
BLBeom Seok Lee
Beom Seok Lee
YLYoung-kyun Lee
Young-kyun Lee
HWHeejae Won
Heejae Won
HKHyungkook Kim
Hyungkook Kim
KKKyung-Hoi Koo
Kyung-Hoi Koo
Lee BS, et al. J Korean Fract Soc. 2018 Oct;31(4):159-164. https://doi.org/10.12671/jkfs.2018.31.4.159

1 July 2017 in The Journal of Foot and Ankle Surgery
Verified
Journal Article
Closed access
PDF file
JBJoo-Yul Bae
Joo-Yul Bae
HWHeejae Won
Heejae Won
DSDong-Kyo Seo
Dong-Kyo Seo